Blue Jet Healthcare Limited (NSE:BLUEJET)

Market Cap	153.49B
Revenue (ttm)	8.73B
Net Income (ttm)	2.35B
Shares Out	173.47M
EPS (ttm)	13.54
PE Ratio	65.34
Forward PE	48.10
Dividend	1.00 (0.11%)
Ex-Dividend Date	n/a

Volume	188,287
Average Volume	432,798
Open	904.00
Previous Close	883.85
Day's Range	874.80 - 904.00
52-Week Range	347.60 - 968.30
Beta	n/a
RSI	59.32
Earnings Date	May 30, 2025

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norw...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1968
• Employees: 447
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BLUEJET

Financial Performance

In 2023, Blue Jet Healthcare's revenue was 7.12 billion, a decrease of -1.30% compared to the previous year's 7.21 billion. Earnings were 1.64 billion, an increase of 2.33%.